- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/18 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans
Patent holdings for IPC class C07K 16/18
Total number of patents in this class: 12017
10-year publication summary
|
821
|
810
|
863
|
832
|
874
|
787
|
793
|
717
|
737
|
682
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1158 |
233 |
| Alexion Pharmaceuticals, Inc. | 639 |
185 |
| Genentech, Inc. | 4016 |
173 |
| Ablynx N.V. | 402 |
144 |
| The Regents of the University of California | 20315 |
142 |
| Amgen Inc. | 4264 |
122 |
| Regeneron Pharmaceuticals, Inc. | 4461 |
121 |
| Chugai Seiyaku Kabushiki Kaisha | 1382 |
109 |
| F. Hoffmann-La Roche AG | 7932 |
107 |
| Eli Lilly and Company | 3942 |
102 |
| Prothena Biosciences Limited | 189 |
102 |
| AC Immune S.A. | 271 |
93 |
| Hoffmann-La Roche Inc. | 3548 |
92 |
| H. Lundbeck A/S | 1247 |
89 |
| The Trustees of the University of Pennsylvania | 4389 |
78 |
| Sanofi | 4142 |
78 |
| Novartis AG | 10595 |
77 |
| Bristol-myers Squibb Company | 4821 |
59 |
| The Johns Hopkins University | 5759 |
59 |
| Abbvie Inc. | 1818 |
58 |
| Other owners | 9794 |